Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

Jefferies London Healthcare Conference 2025 November 20, 2025 9:30 AM ESTCompany ParticipantsPeter Dannenbaum - Vice ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

Deniz Gökengin thinks colleagues view her as “a very serious, hardworking, meticulous, control-freak type of person”. But she ...

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

The United States, whose deep cuts to foreign aid this year under President Trump have severely impacted Africa’s health ...

Malawian student Kondwani has fought against the stigma of being HIV-positive for most of his life, but COVID-19 has reignited old prejudices and given rise to a new term of abuse - "corona carrier".

Valentine Murakatete, a 31-year-old resident of Kibagabaga, began noticing unusual itching on her skin in 2015. What started as a minor irritation soon turned into a burning sensation that spread in ...

Our researchers have worked at the forefront of HIV care, research, education, and policy since the earliest stages of the epidemic. We conduct basic, translational, and implementation research here ...

Staff and residents at iCare Health Network engage in dedicated training and activities designed to counter stigma related to severe mental illness, drug use and diagnoses such as HIV. (Courtesy of ...

A resident exercises in the physical therapy gym at Broadway House for Continuing Care, the only US nursing home to receive funding through the federal Ryan White HIV/AIDS Program. (Photo: Courtesy of ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral therapy (ART) avoided rebound for 5 months, a randomized trial showed. At ...